Prakiraan wutah bathi resik saben saham kanggo taun ngarep NextCure (NXTC)
NextCure, Inc. (NXTC) is minimizing risks by exploring new methods to combat tumor resistance through innovative antibodies. The consensus forward-looking EPS growth forecast visualizes these expectations, where the 78.30 level captures the current state. Successes in clinical trials and partnerships with pharma behemoths are driving growth. Stable demand for healthcare makes the company resilient to macro cycles, tying its development to product commercialization.
Rincian metrik lan analitis perusahaan nextcure.com (NXTC)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- rincian nilai buku perusahaan:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas NextCure, Inc.|NXTC - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas NextCure|NXTC - Tanggungan utang total perusahaan|Utang marang nilai buku NextCure|NXTC - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan NextCure|Rasio cepet nextcure.com
- statistik bathi lan rasio pasar:
NXTC - Penghasilan resik perusahaan|Bathi sing dikarepake NextCure, Inc.|NXTC - Nilai perusahaan marang bathi resik|Pangali Forward P/E NextCure, Inc.|NXTC - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NextCure|NXTC - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan NextCure|NXTC - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nextcure.com|NXTC - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep NextCure, Inc.
Analisis kabeh metrik perusahaan:NextCure Corp
NextCure, Inc. (NXTC) is investing its accumulated reserves into costly immuno-oncology drug development, which temporarily precludes operating profit. Analyzing this earnings per share forecast chart reveals analysts' calculated expectations for next year's EPS dynamics, recorded at 78.30. This metric measures the pace of profitability recovery, allowing investors to assess the timeline for the biotech's transition from a cash-burn stage to profitability.
Pesaing langsung
Prakiraan wutah bathi resik saben saham kanggo taun ngarep ImmunityBio Corp|Prakiraan wutah bathi saben saham kanggo taun ngarep Immunocore Corp (IMCR)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Janux Therapeutics (JANX)|Prakiraan wutah bathi saben saham kanggo taun ngarep arcusbio.com RCUS|Zymeworks - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Tango Therapeutics Inc TNGX|IOVA - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMTX (Immatics Biotechnologies) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Xencor, Inc. (XNCR) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep compasstherapeutics.com (CMPX)|Prakiraan wutah bathi saben saham kanggo taun ngarep REPL|LYEL - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep IPHA (Innate Pharma, S.A.)|Proyeksi tambahing bathi saben saham ing taun ngarep PYXS|Prakiraan wutah bathi kanggo taun ngarep CGEN (Compugen)|Dinamika bathi saben saham sing diarepake ing taun ngarep IOBT|Sutro Biopharma - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep MiNK Therapeutics Inc.|werewolftx.com (HOWL) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Immix Biopharma - Dinamika bathi saben saham sing diarepake ing taun ngarep|ALXO (ALX Oncology Holdings) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep cuebiopharma.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PDS Biotechnology (PDSB)|SONN: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|MAIA Biotechnology Inc - Prakiraan wutah bathi saben saham kanggo taun ngarep|Liminatus (LIMN) - Prakiraan wutah bathi resik saben saham ing taun ngarep|LVTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|LPTX (Leap Therapeutics, Inc.) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|INTS: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Sensei Biotherapeutics, Inc. (SNSE)|Prakiraan wutah bathi saben saham kanggo taun ngarep TOVX|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep GRTS (Gritstone Bio)|Prakiraan wutah bathi saben saham kanggo taun ngarep KA (Kineta, Inc.)|Proyeksi tambahing bathi saben saham ing taun ngarep NEXI|Prakiraan wutah bathi kanggo taun ngarep TSBX (Turnstone Biologics Corp.)|VCNX - Prakiraan wutah bathi saben saham kanggo taun ngarep|HARP: Prakiraan wutah bathi saben saham kanggo taun ngarep
